Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Colonic Neoplasms × Conversion to Open Surgery × Clear all

Phase

Phase NA 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2 Stomach Neoplasms 1 Lung Neoplasms 1 Locally Advanced Gastric Cancer 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Fluorouracil 64 Leucovorin 62 Oxaliplatin 43 Irinotecan 28 Folfox protocol 20 Bevacizumab 20 Capecitabine 19 Cetuximab 13 Chemotherapy, Adjuvant 11 Aspirin 6 Laparoscopy 5 Celecoxib 5 XELOX 4 Panitumumab 4 Levamisole 4 dehydroftorafur 3 Observation 3 Floxuridine 3 tislelizumab 2 pertuzumab 2 encorafenib 2 atezolizumab 2 Trastuzumab 2 Tegafur 2 Surgical Procedures, Operative 2 Standard of Care 2 Semaxinib 2 Octreotide 2 Occult Blood 2 Nivolumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02682589 2016-07-06

OLCMECC

The First Affiliated Hospital with Nanjing Medical University

Phase 3 Unknown

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡